View up-to-date information on Xencor Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP3387013B1 | Grant | CD3 UND PSMA BINDENDE HETERODIMERE ANTIKÖRPER | A61K2039/505; A61K38/02; A61P35/00; C07K16/1027; C07K16/2809; C07K16/3069; C07K16/468; C07K2/00; C07K2317/24; C07K2317/31; C07K2317/52; C07K2317/55; C07K2317/622; C07K2317/66; C07K2317/74; C07K2317/90; C07K2317/92; C12N15/63 | June 08, 2022 |
EP4008726A1 | Application | ANTIKÖRPER DER KOMPLEMENTKOMPONENTE C5 | A61K2039/505; A61K39/00; A61K39/0005; A61K39/3955; A61P27/02; A61P43/00; C07K16/18; C07K2317/24; C07K2317/56; C07K2317/565; C07K2317/76 | June 08, 2022 |
US11352412B2 | Grant | CTLA4-IG immunoadhesins | A61K38/00; C07K14/70521; C07K16/46; C07K19/00; C07K2319/30; C07K2319/31; C07K2319/74 | June 07, 2022 |
US11352442B2 | Grant | Heterodimeric antibodies that bind CD3 and CD38 | A61K2039/505; C07K16/18; C07K16/2809; C07K16/2896; C07K16/3061; C07K16/40; C07K2317/24; C07K2317/31; C07K2317/33; C07K2317/522; C07K2317/524; C07K2317/526; C07K2317/55; C07K2317/56; C07K2317/565; C07K2317/567; C07K2317/622; C07K2317/64; C07K2317/73; C07K2317/92 | June 07, 2022 |
US20220162313A1 | Application | HETERODIMERIC ANTIBODIES THAT BIND SOMATOSTATIN RECEPTOR 2 | A61K2039/505; A61P35/00; C07K16/2809; C07K16/2869 | May 26, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer